Lentiviral vectors ready for prime-time
Article Abstract:
The first clinical trials using lentiviral vector has shown efficient and safe gene delivery to the patients' T cells with good persistence in vivo and also to treat a large number of disorders. Lentiviral vectors are the main elements in advancing gene therapy to expand the conditions and might respond, beyond the primary immune deficiencies that have constituted the sole success to date using gamma-retroviral vectors.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Bioinformatics prediction of HIV coreceptor usage
Article Abstract:
A comprehensive summary of the study of viral coreceptor usage is presented with emphasis on the utility and capability of bioinformatics techniques.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Continuous high-titer HIV-1 vector production
Article Abstract:
HIV-1 vector production is mapped and analyzed.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The impact of costly information interpretation on firm disclosure decisions. The forecast accuracy of individual analysts: evidence of systematic optimism and pessimism
- Abstracts: Living trusts may provide tax benefits. IRS explains medical savings accounts
- Abstracts: Huntington builds the "bricks and mortar" of the information age. Beyond textbook asset-liability management
- Abstracts: New tools transform database marketing. Information provides insight, competitive marketing edge
- Abstracts: Comments on efficiency studies. Issues in the credit risk modeling of retail markets